Lysinuric protein intolerance: One gene, many problems

American Journal of Physiology - Cell Physiology

Volumn 293, Issue 2, 2007, Pages

  Bröer, Stefan ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; CITRULLINE; LYSINE;

DIET RESTRICTION; DIET SUPPLEMENTATION; EDITORIAL; HEPATOMEGALY; HUMAN; LUNG ALVEOLUS PROTEINOSIS; LYSINURIC PROTEIN INTOLERANCE; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTOLERANCE; PROTEIN METABOLISM; SPLENOMEGALY; SYMPTOMATOLOGY; URINALYSIS;

AMINO ACID METABOLISM, INBORN ERRORS; AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; ANTIGENS, CD98 LIGHT CHAINS; GENE EXPRESSION PROFILING; GENOTYPE; HUMANS; LYSINE; MICE; MICE, KNOCKOUT; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIB;

EID: 34547767001     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00166.2007     Document Type: Editorial

References (21)

1. Borsani G, Bassi MT, Sperandeo MP, De Grandi A, Buoninconti A, Riboni M, Manzoni M, Incerti B, Pepe A, Andria G, Ballabio A, Sebastio G. SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance. Nat Genet 21: 297-301, 1999.
2. Broer A, Wagner CA, Lang F, Broer S. The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux in exchange with glutamine. Biochem J 349: 787-795, 2000.
3. Esposito V, Lettiero T, Fecarotta S, Sebastio G, Parenti G, Salerno M. Growth hormone deficiency in a patient with lysinuric protein intolerance. Eur J Pediatr 165: 763-766, 2006.
4. Knopf RF, Conn JW, Fajans SS, Floyd JC, Guntsche EM, Rull JA. Plasma growth hormone response to intravenous administration of amino acids. J Clin Endocrinol Metab 25: 1140-1144, 1965.
5. Milne MD. Disorders of amino-acid transport. Br Med J 5379: 327-336, 1964.
6. Palacin M, Bertran J, Chillaron J, Estevez R, Zorzano A. Lysinuric protein intolerance: mechanisms of pathophysiology. Mol Genet Metab 81, Suppl: 27-37, 2004.
7. Pfeiffer R, Rossier G, Spindler B, Meier C, Kuhn L, Verrey F. Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family. Embo J 18: 49-57, 1999.
8. Rajantie J, Simell O, Perheentupa J. Basolateral-membrane transport defect for lysine in lysinuric protein intolerance. Lancet 1: 1219-1221, 1980.
9. Rajantie J, Simell O, Perheentupa J. Intestinal absorption in lysinuric protein intolerance: impaired for diamino acids, normal for citrulline. Gut 21: 519-524, 1980.
10. Rotoli BM, Dall'asta V, Barilli A, D'Ippolito R, Tipa A, Olivieri D, Gazzola GC, Bussolati O. Alveolar macrophages from normal subjects lack the NOS-related system y+ for arginine transport. Am J Respir Cell Mol Biol. In press.
11. Shoji Y, Noguchi A, Shoji Y, Matsumori M, Takasago Y, Takayanagi M, Yoshida Y, Ihara K, Hara T, Yamaguchi S, Yoshino M, Kaji M, Yamamoto S, Nakai A, Koizumi A, Hokezu Y, Nagamatsu K, Mikami H, Kitajima I, Takada G. Five novel SLC7A7 variants and y+L gene-expression pattern in cultured lymphoblasts from Japanese patients with lysinuric protein intolerance. Hum Mutat 20: 375-381, 2002.
12. Simell O, Perheentupa J, Rapola J, Visakorpi JK, Eskelin LE. Lysinuric protein intolerance. Am J Med 59: 229-240, 1975.
13. Sperandeo MP, Annunziata P, Bozzato A, Piccolo P, Maiuri L, D'Armiento M, Ballabio A, Corso G, Andria G, Borsani G, Sebastio G. Slc7a7 disruption causes fetal growth retardation by downregulating Igf1 in the mouse model of lysinuric protein intolerance. Am J Physiol Cell Physiol 293: C191-C198, 2007. First published March 21, 2007; doi:10.1152/ajpcell.00583.2006.
14. Tanner LM, Nanto-Salonen K, Niinikoski H, Huoponen K, Simell O. Long-term oral lysine supplementation in lysinuric protein intolerance. Metabolism 56: 185-189, 2007.
15. Torrents D, Estevez R, Pineda M, Fernandez E, Lloberas J, Shi YB, Zorzano A, Palacin M. Identification and characterization of a membrane protein (y+L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y+L. A candidate gene for lysinuric protein intolerance. J Biol Chem 273: 32437-32445, 1998.
16. Torrents D, Mykkanen J, Pineda M, Feliubadalo L, Estevez R, de Cid R, Sanjurjo P, Zorzano A, Nunes V, Huoponen K, Reinikainen A, Simell O, Savontaus ML, Aula P, Palacin M. Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene. Nat Genet 21: 293-296, 1999.
17. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 349: 2527-2539, 2003.
18. Tsumura H, Suzuki N, Saito H, Kawano M, Otake S, Kozuka Y, Komada H, Tsurudome M, Ito Y. The targeted disruption of the CD98 gene results in embryonic lethality. Biochem Biophys Res Commun 308: 847-851, 2003.
19. Vaquero J, Butterworth RF. The brain glutamate system in liver failure. J Neurochem 98: 661-669, 2006.
20. Verrey F, Meier C, Rossier G, Kuhn LC. Glycoprotein-associated amino acid exchangers: broadening the range of transport specificity. Pflügers Arch 440: 503-512, 2000.
21. Wagner CA, Lang F, Broer S. Function and structure of heterodimeric amino acid transporters. Am J Physiol Cell Physiol 281: C1077-C1093, 2001.